Beyond CRP and SAA: Proteomics reveals a combined CR2 and VSIG4 signature for severity in influenza and COVID-19 pneumonia
Molecular Immunology · 2026-11 · 199 · 114-128
DOI: 10.1016/j.molimm.2026.09.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Immunology, 2026-11. Verfasst von Lifang Liang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing, China; National Center for …. Hauptthemen laut MEDLINE: COVID-19, C-Reactive Protein, Serum Amyloid A Protein, Influenza, Human. Die Arbeit nennt 42 Literaturangaben. Gefördert von: China-Japan Friendship Hospital, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Innate immune molecules like CRP and SAA are established biomarkers in bacterial pneumonia, but their role in viral CAP is rarely investigated. METHODS: Untargeted proteomics was analyzed in two discovery cohorts: an influenza-associated severe CAP cohort of 16 patients and 16 controls; and a longitudinal COVID-19-dominant CAP cohort of 15 patients at three time points and 15 controls. Analyses focused on innate immune molecules. Selected candidates were evaluated by ELISA using available samples from the discovery cohorts and further validated in an independent validation cohort of 28 viral CAP patients and 28 HCs. RESULTS: CRP, SAA1, and SAA2 were consistently upregulated across both cohorts. In the COVID-19 cohort stratified by severity, the invasive mechanical ventilation subgroup showed elevated VSIG4 and decreased CR2. ELISA/ROC analyses confirmed SAA1/SAA2 significantly elevated in CAP patients, with excellent diagnostic performance (AUC=1.000) but limited severity discrimination. Public COVID-19 cohorts further supported increased VSIG4 expression in severe and fatal disease. The CR2 and VSIG4 combination showed good performance in distinguishing patients requiring invasive mechanical ventilation from those on oxygen/non-invasive support (AUC=0.854) or no support (AUC=0.969). CONCLUSION: CRP, SAA1, and SAA2 are reliable diagnostic markers for CAP, while CR2 + VSIG4 may aid severity stratification. These findings highlight innate immune molecules as potential biomarker panels for diagnosing and risk assessment in viral respiratory infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing, China; National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and M…
- National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of…
- School of Basic Medical Sciences, Tsinghua University, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China.
- Department of Clinical Microbiology, Pulmonary and Critical Care Medicine, Zibo City Key Laboratory of Respiratory Infection and Clinical Microbiology, Zibo City Engineering Technology Research Center of Etiology Molecu…
- Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China; Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
- Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
Förderung
- China-Japan Friendship Hospital
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences
Zitieren
APA
Liang, L., Huang, L., Wang, Y., Xu, J., Huang, Y., Cao, H., Yuan, Y., Wang, W., He, Y., Qiu, L., Zhan, Q., Wang, Z., & Cao, B. (2026). Beyond CRP and SAA: Proteomics reveals a combined CR2 and VSIG4 signature for severity in influenza and COVID-19 pneumonia. Molecular Immunology, 199, 114-128. https://doi.org/10.1016/j.molimm.2026.09.007
Vancouver
Liang L, Huang L, Wang Y, Xu J, Huang Y, Cao H, et al. Beyond CRP and SAA: Proteomics reveals a combined CR2 and VSIG4 signature for severity in influenza and COVID-19 pneumonia. Molecular Immunology. 2026;199:114-128. doi:10.1016/j.molimm.2026.09.007
BibTeX
@article{Liang2026,
author = {Liang, Lifang and Huang, Linna and Wang, Yimin and Xu, Jiuyang and Huang, Yijiao and Cao, Hongyun and Yuan, Yingying and Wang, Weiyang and He, Yanhua and Qiu, Lijie and Zhan, Qingyuan and Wang, Zai and Cao, Bin},
title = {Beyond CRP and SAA: Proteomics reveals a combined CR2 and VSIG4 signature for severity in influenza and COVID-19 pneumonia},
journal = {Molecular Immunology},
year = {2026},
volume = {199},
pages = {114--128},
doi = {10.1016/j.molimm.2026.09.007}
}
EUVIMED